In this episode, Prof Chapman takes a hard look at the growing menu of tests and treatments marketed to women after recurrent miscarriage — and asks a simple question: where's the evidence? He unpacks the $1,500 endometrial receptivity test that took eight years and a gold-standard trial to show no benefit, the same company's pivot to uterine microbiome testing, and the murky world of immunological treatments like steroids, intralipid and immunoglobulins. Along the way he separates the genuinely useful (spotting and treating chronic endometritis, working on smoking and weight) from what he calls "bad medicine." The number that reframes everything? Even after four miscarriages, a woman's chance of carrying a baby next time — doing nothing at all — is still well over 60 to 70%. A clear-eyed, honest conversation about knowing which interventions are worth it, and which are just being sold.
Explore the 'Prof. Michael Chapman - The IVF Journey' Facebook Page, your reliable destination for cutting-edge insights and guidance within
the realm of In Vitro Fertilization (IVF).
Don't miss out on the IVF Journey podcast; stay informed with the latest episode updates. Tune in for expert discussions and valuable information on navigating the intricate path of IVF.
